Clinical Trials Browser

OTHER × Metabolic Syndrome × Metformin × Clear all

NCT07380841 2026-02-02

PCOS-COMBO (9)

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Phase 4 Terminated

3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT03031821 2024-10-04

PRIME

Phase 3 Terminated

Prostatic Neoplasms, Metabolic Syndrome

NCT01996696 2024-01-30

PREMIUM

Phase 2 Terminated

Prostatic Neoplasms, Weight Gain, Metabolic Syndrome

NCT00988078 2012-06-26

Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome

Phase NA Unknown

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00317928 2006-10-11

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors

Phase NA Unknown

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome